T1DM Patients With Active β-Cell Function Differ Immunologically

Share this content:
T1DM Patients With Active β-Cell Function Differ Immunologically
T1DM Patients With Active β-Cell Function Differ Immunologically

FRIDAY, June 30, 2017 (HealthDay News) -- Patients with remaining endogenous β-cell function after a decade of living with type 1 diabetes tend to have much higher levels of interleukin-35 (IL-35) than other patients with long-standing type 1 diabetes, according to a study published in the June issue of Diabetes Care.

Daniel Espes, M.D., of Uppsala University in Sweden, and colleagues reached their conclusions after studying 113 patients with type 1 diabetes. The disease duration of participating patients was 10 or more years.

The investigators found that approximately 40 percent of patients with type 1 diabetes and 10 or more years disease duration had measurable fasting C-peptide concentrations. The team also found that blood plasma IL-35 concentrations were noted to be twice as high in the patients with remaining C-peptide.

"Patients with remaining endogenous β-cell function after >10 years duration of type 1 diabetes differ immunologically from other patients with long-standing type 1 diabetes," the authors conclude. "In particular, they have a much higher IL-35 production."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Florida Teen First Human Case of Another Mosquito-Borne Virus

Florida Teen First Human Case of Another Mosquito-Borne ...

First documented case of Keystone infection in a human

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

Illnesses reported in Illinois, Indiana, Kentucky, Michigan, Missouri, Ohio, and Tennessee

AAFP Still Recommends CRC Screening From Age 50 to 75

AAFP Still Recommends CRC Screening From Age 50 ...

Despite ACS change to start screening from age 45 years, AAFP agrees with USPSTF recommendation

is free, fast, and customized just for you!




Already a member?

Sign In Now »